Brief: Inhalation Sciences Sweden Q4 Operating Loss Widens To SEK 4.3 Million
25/02/2021 07:13
Feb 25 (Reuters) - Inhalation Sciences Sweden AB ISAB.TE :
* Q4 NET SALES SEK 2.1 MILLION VERSUS SEK 3.8 MILLION YEAR
AGO
* Q4 OPERATING LOSS SEK 4.3 MILLION VERSUS LOSS SEK 2.0
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr26HrDy
Further company coverage: ISAB.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Inhalation Sciences Sweden AB
See all newsBrief: Inhalation Sciences Gets Order Of EUR 60,000 From Long-Term Big Pharma Client
Brief: Inhalation Sciences Announces Outcome Of The Rights Issue
Brief: Inhalation Sciences Sweden Q4 Operating Loss Widens To SEK 4.3 Million
Brief: Inhalation Sciences Receives New Order From Aquilon Pharma
Brief: Inhalation Sciences Receives New Order From University Of Vienna